Cooke Graham S, Tosh Kerrie, Ramaley Patricia A, Kaleebu Pontiano, Zhuang Joanna, Nakiyingi Jessica S, Watera Christine, Gilks Charles F, French Neil, Whitworth James A G, Hill Adrian V S
Wellcome Trust Centre for Human Genetics, Churchill Hospital, University of Oxford, Oxford, United Kingdom, OX3 7BN.
J Infect Dis. 2006 Sep 1;194(5):666-9. doi: 10.1086/505875. Epub 2006 Jul 28.
We investigated the effect of RANTES polymorphisms on human immunodeficiency virus type 1 (HIV-1) disease progression in an urban population of Uganda. HIV-positive individuals homozygous for the INT1.1C polymorphism, which had been associated previously with low RANTES expression, were less likely to die than were those with other genotypes (hazard ratio, 0.53 [95% confidence interval, 0.33-0.83]; P=.007). This report of a non-human leukocyte antigen genetic association with HIV-1 and/or acquired immunodeficiency syndrome disease progression in an African population reveals a genetic effect different from that reported elsewhere for African Americans and may impact therapeutic strategies targeting the RANTES pathway in HIV infection.
我们在乌干达城市人群中研究了RANTES基因多态性对1型人类免疫缺陷病毒(HIV-1)疾病进展的影响。INT1.1C基因多态性纯合的HIV阳性个体,此前已被证明与RANTES低表达相关,与其他基因型个体相比,其死亡可能性更低(风险比为0.53[95%置信区间为0.33 - 0.83];P = 0.007)。本报告指出在非洲人群中一种非人类白细胞抗原基因与HIV-1和/或获得性免疫缺陷综合征疾病进展存在关联,这揭示了一种与非裔美国人中所报道的不同的基因效应,并且可能会影响针对HIV感染中RANTES途径的治疗策略。